Application progress of non-vitamin K antagonist oral anticoagulants in hypertrophic cardiomyopathy with atrial fibrillation / 中国医师杂志
Journal of Chinese Physician
; (12): 1750-1754, 2023.
Article
in Zh
| WPRIM
| ID: wpr-1026024
Responsible library:
WPRO
ABSTRACT
Atrial fibrillation (AF) is the most common supraventricular arrhythmia in patients with hypertrophic cardiomyopathy. Patients with hypertrophic cardiomyopathy and atrial fibrillation have a significantly increased risk of thromboembolism. Currently, guidelines recommend lifelong anticoagulant therapy for all such patients. The data on the use of non-vitamin K antagonist oral anticoagulants in patients with hypertrophic cardiomyopathy and atrial fibrillation are limited, and their efficacy and safety are not well established. This article provides a review of the current evidence on this issue.
Full text:
1
Index:
WPRIM
Language:
Zh
Journal:
Journal of Chinese Physician
Year:
2023
Type:
Article